Stock activists fire back at Allergan’s defensive moves, push for a company sale
Allergan’s attempt to assuage its critics — or at least shore up support among investors — by adding industry headliner Bob Hugin to the board and calling for an eventual division of the chairman and CEO roles at the company has inspired a wicked backlash.
Hours after Allergan $AGN posted the move, saying it would separate the two top roles during an eventual leadership transition, its activist critics at Appaloosa LP — helmed by Carolina Panthers owner David Tepper — posted a letter bashing Allergan’s move in no uncertain terms. And they go on to say that it would be better for Allergan to go ahead and explore other options, like a sale of the company.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.